Intelligent Bio Solutions Inc. (INBS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
애널리스트 추정 주당순이익(EPS) $-36.70 및 매출 $0.00B 다음 회계연도.
주당순이익(EPS) 실적 추이: 2024: 실적 $-6.38 vs 추정 $-36.70 (상회 +82.6%). 2025: 실적 $-20.00 vs 추정 $-12.50 (하회 -60%). 애널리스트 정확도: 0%.
EPS 전망 — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$6.38
vs Est –$36.70
▲ 475.2% off
2025
Actual –$20.00
vs Est –$12.50
▼ 37.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
매출 전망 — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.004B
▼ 35.0% off
2025
Actual $0.003B
vs Est $0.012B
▼ 280.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
